Page last updated: 2024-12-08

glycylprolylglycine amide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glycylprolylglycine amide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID456396
SCHEMBL ID1046072
MeSH IDM0386507

Synonyms (22)

Synonym
gpg-nh2
glycinamide, glycyl-l-prolyl
glycyl-prolyl-glycyl amide
glycyl-prolyl-glycyl amide; gpg-nh2
(2s)-1-(2-aminoacetyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide
glycylprolylglycine amide
SCHEMBL1046072
unii-73gv270z6z
glycyl-prolyl-glycine amide
glycinamide, glycyl-l-prolyl-
glycinamide, glycyl-prolyl-
(2s)-1-(aminoacetyl)-n-(carbamoylmethyl)pyrrolidine-2-carboxamide
gly-pro-gly-nh2
glycyl-l-prolylglycinamide
73GV270Z6Z ,
141497-12-3
h-gly-pro-gly-nh2
glycyl-prolyl-glycinamide
Q27266174
CS-0653409
PD161520
HY-P4292
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]